Joe Zabreski
President & Chief Executive Officer
Replay available
Molina Healthcare Inc (NYSE: MOH) Q2 2025 earnings conference call, held 2025-07-24. Replay captured from the company's public earnings webcast.

President & Chief Executive Officer
Vice President, Investor Relations
Executive Vice President & Chief Financial Officer
Analyst, Barclays
Analyst, Neffron Research
Analyst, Wells Fargo Securities
Analyst, Wolfe Research
Analyst, Bank of America
Analyst, TD Cowen
Analyst, Cantor Fitzgerald
Analyst, JPMorgan
Analyst, UBS
Analyst, Blackbeard
Analyst, Guggenheim
Analyst, Deutsche Bank
Good day and welcome to the Molina Healthcare Second Quarter 2025 earnings conference call. All participants will be in listen-only mode. Should you need assistance, please signal a conference specialist by pressing the star key followed by zero. After today's presentation, there will be an opportunity to ask questions. To ask a question, you may press star, then one, on your telephone keypad. To withdraw your question, please press star, then two. Please note, this event has been recorded. I would now like to turn the conference over to Jeff Geyer, Vice President of Investor Relations. Please go ahead. Good morning and welcome to Molina Healthcare's Second Quarter 2025 earnings call. Joining me today are Molina's President and CEO Joe Zabreski and our CFO Mark Keim. A press release announcing our Second Quarter 2025 earnings was distributed after the market closed yesterday and is available on our Investor Relations website. Shortly after the conclusion of this call, a replay will be available for 30 days. The numbers to access the replay are in the earnings release. For those of you who listened to the rebroadcast of this presentation, we remind you that all of the remarks are made as of today, Thursday, July 24th, 2025, and have not been updated subsequent to the initial earnings call. On this call, we will refer to certain non-GAAP measures. A reconciliation of these measures with the most directly comparable GAAP measures can be found in the Second Quarter 2025 earnings release. During the call, we will be making certain forward-looking statements, including, but not limited to, statements regarding our 2025 guidance and 2025 guidance elements, the medical cost trend and our projected MCRs, Medicaid rate adjustments and updates, our 2026 marketplace pricing and ...